Edition:
United States

Health News

Akorn gets another FDA warning letter, shares slide

Akorn Inc said on Tuesday it received a warning letter from the U.S. Food and Drug Administration regarding its manufacturing facility in New Jersey, the latest in a string of setbacks for the generic drugmaker, sending its shares down nearly 13%.

Health Reform Watch